Skip to content

The Effect of Dexmedetomidine on Propofol Requirement for Insertion of Laryngeal Mask Airway

The Effect of Dexmedetomidine on Propofol Requirement for Insertion of Laryngeal Mask Airway

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02284672
Enrollment
39
Registered
2014-11-06
Start date
2014-11-30
Completion date
2016-01-31
Last updated
2016-02-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Precedex Effect to Propofol Requirement

Brief summary

Propofol frequently used as an inducting medication for insertion Laryngeal mask airway(LMA). But propofol alone can be not sufficient for inhibiting upper airway reflex and also result in cardiovascular suppression under enough amount. Dexmedetomidine is a selective alplh2 receptor agonist with analgesic and sedative effects but sparing respiratory function. Therefore propofol combined with dexmedetomidine induction could be more effective in preserve respiration under same condition for LMA insertion than propofol alone. In this study, the investigators investigate the clinical dose of propofol for LMA insertion with premedication of dexmedetomidine, and evaluate the effect of dexmedetomidine.

Interventions

DRUGDexmedetomidine
DRUGNormal saline

Sponsors

Ajou University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
19 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* patients for surgery not exceed more than 2 hours requiring general anesthesia

Exclusion criteria

* history of gastroesophageal reflux High grade obesity Predicted diffiicult airway

Design outcomes

Primary

MeasureTime frameDescription
Fail or success for Laryngeal Mask Airway (LMA) insertionDuring inserting LMA and up to 5 seconds after LMA inserionFailure for LMA insertion is defined if there is a difficulty for mouth opening or active movement of four limbs or head. Success is smooth LMA insertion without any movement

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026